정상 갑상샘 기능을 보이는 성인 남성에서 갑상샘 호르몬과 대사증후군 위험요인과의 관계
Association between Thyroid Hormone and Risk Factors of Metabolic Syndrome in Adult Men of Normal Thyroid Function
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Thyroid hormones are essential for cellular energy homeostasis and regulation by interacting with the sympathetic nervous system. This study was conducted to investigate the relationship between thyroid hormone and risk factors of metabolic syndrome for medical checkups of male patients. The study subjects were 12,250 males between 20∼80 years old who visited the hospital for a health check-up at one General Hospital in Gyeonggi-do during the period of January 2011 to December 2013. According to the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), the metabolic syndrome criteria is defined as the presence of 3 or more risk factors. FT4 was lower in the metabolic syndrome group than in the normal group (p＜0.001). The level of FT4 decreased as the levels of abdominal obesity (p=0.001), hypertriglyceridemia (p＜0.001), blood pressure (p=0.005) and blood glucose (p=0.005) increased. The TSH level increased hypertriglyceridemia (p=0.047). FT4 had an influence on the waist circumference and triglyceride (p＜0.001). HbA1c, insulin, HOMA-IR, hs-CRP were higher in the lowest quartile than in the highest quartile (p＜0.001). FT4 had effects on the waist circumference and triglyceride, but TSH had no effect on metabolic syndrome risk factors. The metabolic syndrome was lower in the highest quartile of FT4 than in its lowest quartile.
Abstract
Thyroid hormones are essential for cellular energy homeostasis and regulation by interacting with the sympathetic nervous system. This study was conducted to investigate the relationship between thyroid hormone and risk factors of metabolic syndrome for medical checkups of male patients. The study subjects were 12,250 males between 20∼80 years old who visited the hospital for a health check-up at one General Hospital in Gyeonggi-do during the period of January 2011 to December 2013. According to the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI), the metabolic syndrome criteria is defined as the presence of 3 or more risk factors. FT4 was lower in the metabolic syndrome group than in the normal group (p＜0.001). The level of FT4 decreased as the levels of abdominal obesity (p=0.001), hypertriglyceridemia (p＜0.001), blood pressure (p=0.005) and blood glucose (p=0.005) increased. The TSH level increased hypertriglyceridemia (p=0.047). FT4 had an influence on the waist circumference and triglyceride (p＜0.001). HbA1c, insulin, HOMA-IR, hs-CRP were higher in the lowest quartile than in the highest quartile (p＜0.001). FT4 had effects on the waist circumference and triglyceride, but TSH had no effect on metabolic syndrome risk factors. The metabolic syndrome was lower in the highest quartile of FT4 than in its lowest quartile.
참고문헌 (29)
- Agarwal G, "The prevalence of thyroid dysfunction among south Indian women with metabolic syndrome", JCDR, 5(2), pp.152~154 (2011)
- Andersen S, "Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease", J Clin Endocrinol Metab, 87(3), pp.1068~1072 (2002)
- da Costa VM, "Thyroid function and aging: gender-related differences", J Endocrinol, 171(1), pp.193~198 (2001)
- Di Bello V, "Early abnormalities of left ventricular myocardial characteristics associated with subclinical hyperthyroidism", J Endocrinol Invest, 30(7), pp.564~571 (2007)
- Duntas LH., "Thyroid disease and lipids", Thyroid, 12(4), pp.287~293 (2002)
- Duntas LH, "Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism", Thyroid, 12(11), pp.1003~1007 (2002)
- Fommei E, "The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans", J Clin Endocrinol Metab, 87(5), pp.1996~2000 (2002)
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112(17), 2735~2752
- Hak AE, "Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women:the Rotterdam Study", Ann Intern Med, 132(4), pp.270~278 (2000)
- Hamburg NM, "Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease", Am J Cardiol, 101(1), pp.82~88 (2008)
- Iwen KA, "Thyroid hormones and the metabolic syndrome", Eur Thyroid J, 2(2), pp.83~92 (2013)
- 정찬희, "한국인에서 갑상선기능에 따른 지질, hsCRP, 허리둔부비와 같은 심혈관질환의 위험인자의 변화", 대한내과학회지, 63(3), pp.5~282 (2002), 대한내과학회
- Kragelund C, "Metabolic syndrome and mortality in stable coronary heart disease:relation to gender", Int J Cardiol, 121(1), pp.62~67 (2007)
- Krishna G, "Effects of thyroid hormones on adenyl cyclase in adipose tissue and on free fatty acid mobilization", Proc Natl Acad Sci, 59(3), pp.884~889 (1968)
- Miranda PJ, "Metabolic syndrome:definition, pathophysiology, and mechanisms", Am Heart J, 149(1), pp.33~45 (2005)
- 나은희, "여성에서 갑상샘 기능과 심혈관계 질환의 위험인자와의 관계", Annals of Laboratory Medicine, 29(4), pp.286~292 (2009), 대한진단검사의학회
- 오상우, "Obesity and Metabolic Syndrome in Korea", Diabetes and Metabolism Journal, 35(6), pp.561~566 (2011), 대한당뇨병학회
- Pangaluri R, "Prevalence of metabolic syndrome and its components in women with subclinical hypothyroidism", Asian J Pharm Clin Res, 6(4), pp.82~84 (2013)
- Papanicolaou DA, "Euthyroid Sick Syndrome and the role of cytokines", Rev Endocr Metab Disord, 1(1-2), pp.43~48 (2000)
- Portella RB, "Altered cardiovascular vagal responses in nonelderly female patients with subclinical hyperthyroidism and no apparent cardiovascular disease", Clin Endocrinol (Oxf), 67(2), pp.290~294 (2007)
- Ridker PM, "Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease", JAMA, 285(19), pp.2481~2485 (2001)
- Roberts WL, "CDC", AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: laboratory tests available to assess inflammation-performance and standardization: a background paper, 2004, pp.110(25), 572~576
- Roos A, "Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects", J Clin Endocrinol Metab, 92(2), pp.491~496 (2007)
- Silva JE, "Thyroid hormone control of thermogenesis and energy balance", Thyroid, 5(6), pp.481~492 (1995)
- 서정열, "갑상선기능 이사에 따른 혈중 CRP,apolipoprotein A-1,apolipoprotein B 및 Lp(a)농도의 양상", 대한내과학회지, 64(4), pp.388~395 (2003), 대한내과학회
- Torrance CJ, "Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats", Endocrinology, 138(3), pp.1204~1214 (1997)
- Walton KW, "The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131-I-low-density lipoproteins in hypothyroidism and thyrotoxicosis", Clin Sci, 29(2), pp.217~238 (1965)
- Wang H, "Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion", Am J Physiol Endocrinol Metab, 286(1), pp.1~7 (2004)
- Waring AC, "Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study", Clin Endocrinol (Oxf), 76(6), pp.911~918 (2012)